Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) issued an announcement. On August 28, 2026, the board of directors resolved to grant 100 A share option incentive recipients a total of 7251,000 A-share options on the same day in accordance with the 2025 A-share option plan (corresponding to 7251,000 A-share company A shares, accounting for about 0.0272% of the total number of shares issued by the company as of the date of this announcement). According to the 2025 A-share options plan, the reserved exercise price for A-share options is RMB 27.93 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.